Durando X - Search Results

1

Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer.

Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon F, Planchat E, Abrial C, Mouret-Reynier MA, Durando X, Barthomeuf C, Chollet P. Bayet-Robert M, et al. Among authors: durando x. Cancer Biol Ther. 2010 Jan;9(1):8-14. doi: 10.4161/cbt.9.1.10392. Epub 2010 Jan 21. Cancer Biol Ther. 2010. PMID: 19901561 Clinical Trial.

2

High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.

Durando X, Lemaire JJ, Tortochaux J, Van-Praagh I, Kwiatkowski F, Vincent C, Bailly C, Verrelle P, Irthum B, Chazal J, Bay JO. Durando X, et al. Bone Marrow Transplant. 2003 Apr;31(7):559-64. doi: 10.1038/sj.bmt.1703889. Bone Marrow Transplant. 2003. PMID: 12692621

3

Methionine dependency and cancer treatment.

Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P. Cellarier E, et al. Among authors: durando x. Cancer Treat Rev. 2003 Dec;29(6):489-99. doi: 10.1016/s0305-7372(03)00118-x. Cancer Treat Rev. 2003. PMID: 14585259 Review.

4

Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial.

Thivat E, Durando X, D'Incan M, Cure H, Mouret-Reynier MA, Madelmont JC, Souteyrand P, Chollet P. Thivat E, et al. Among authors: durando x. Anticancer Drugs. 2005 Oct;16(9):1003-7. doi: 10.1097/01.cad.0000176506.71304.ca. Anticancer Drugs. 2005. PMID: 16162977 Clinical Trial.

5

Neoadjuvant endocrine therapy in breast cancer.

Abrial C, Mouret-Reynier MA, Curé H, Feillel V, Leheurteur M, Lemery S, Le Bouëdec G, Durando X, Dauplat J, Chollet P. Abrial C, et al. Among authors: durando x. Breast. 2006 Feb;15(1):9-19. doi: 10.1016/j.breast.2005.07.009. Epub 2005 Oct 17. Breast. 2006. PMID: 16230013 Review.

6

Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.

Durando X, Thivat E, D'Incan M, Sinsard A, Madelmont JC, Chollet P. Durando X, et al. BMC Cancer. 2005 Nov 15;5:147. doi: 10.1186/1471-2407-5-147. BMC Cancer. 2005. PMID: 16287507 Free PMC article.

7

Does survival increase in metastatic breast cancer with recently available anticancer drugs?

Abrial C, Leheurteur M, Cabrespine A, Mouret-Reynier MA, Durando X, Ferriere JP, Kwiatkowski F, Penault-Llorca F, Cure H, Chollet P. Abrial C, et al. Among authors: durando x. Oncol Res. 2006;15(9):431-9. doi: 10.3727/096504005776568264. Oncol Res. 2006. PMID: 16555549

8

Cystemustine in recurrent high grade glioma.

Durando X, Thivat E, Roché H, Bay JO, Lemaire JJ, Verrelle P, Chazal J, Curé H, Chollet P. Durando X, et al. J Neurooncol. 2006 Aug;79(1):33-7. doi: 10.1007/s11060-005-9096-7. Epub 2006 Mar 31. J Neurooncol. 2006. PMID: 16575534 Clinical Trial.

9

Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.

Gimbergues P, Dauplat MM, Cayre A, Durando X, Le Bouedec G, Finat-Duclos F, Portefaix G, Kwiatkowski F, Dauplat J, Penault-Llorca F, Tchirkov A. Gimbergues P, et al. Among authors: durando x. Eur J Surg Oncol. 2007 Feb;33(1):16-22. doi: 10.1016/j.ejso.2006.09.013. Epub 2006 Oct 27. Eur J Surg Oncol. 2007. PMID: 17071045

10

Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer.

Chollet P, Abrial C, Tacca O, Mouret-Reynier MA, Leheurteur M, Durando X, Curé H. Chollet P, et al. Among authors: durando x. Clin Breast Cancer. 2006 Oct;7(4):336-8. doi: 10.3816/CBC.2006.n.047. Clin Breast Cancer. 2006. PMID: 17092402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page